Foreign exchangepositive · 4 filings
“2026, total international sales increased primarily due to favorable changes in foreign exchange rates and improved average selling prices, partially offset by lower pump and supply volumes.”10-Q · May 7, 2026 ↗
Tandem Diabetes Care, Inc.
TNDM
Market read
Tandem Diabetes Care, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.
Company-6.9% todayVolume comparison unavailable
Market group0 of 10 activeMedia & Financial Services · unavailable
Disclosed network0 of 7 confirmingNo filing-linked name is confirming now
What would change this read
Watch this read- TNDM's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if TNDM's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.
Evidence that supports
No thresholded supportive filing evidence is available yet.
Evidence that challenges
No thresholded adverse filing evidence is available yet.
What would clarify the read
- TNDM's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Business model and earnings drivers
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
Key research questions
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
Annual periods9
Price observations319
Usable filing statements75
Verified relationships6
Evidence supporting the case
- Latest annual revenue changed +7.9% year over year.
- Foreign exchange has repeated favorable evidence across 4 filings.
Evidence challenging the case
- Operating margin changed -7.9 percentage points in the latest annual period.
- Net margin changed -10.0 percentage points in the latest annual period.
- Diluted shares increased 2.8% in the latest annual period.
- Restructuring and cost reductions has repeated adverse evidence across 4 filings.
- Credit and interest rates has repeated adverse evidence across 3 filings.
Questions before a position
- EV/sales is 57% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context
Price as of Sep 10, 2026
18.316m-27.6%12m+49.5%24m—
Annual trajectory
Reported annual revenue and per-share history. This is accounting history, not a forecast.
PeriodRevenueYoYDiluted EPSShare change
2021-12-31$702.8M+40.9%$0.24+5.5%
2022-12-31$801.2M+14.0%$-1.47-0.3%
2023-12-31$747.7M-6.7%$-3.43+1.3%
2024-12-31$940.2M+25.7%$-1.47+0.7%
2025-12-31$1.0B+7.9%$-3.04+2.8%
What management says matters
Persistent and emerging business drivers
Restructuring and cost reductionsnegative · 4 filings
“The decrease in R&D expenses was primarily driven by a reduction of one-time charges of $2.3 million for non-recurring restructuring costs incurred in the first quarter 2025.”10-Q · May 7, 2026 ↗
Credit and interest ratesnegative · 3 filings
“Other income, net for 2024 primarily consisted of $22.1 million of interest income earned on our cash equivalents and short-term investments, offset by $7.4 million of interest expense, $2.1 million in losses attributable to equity method investments, $2.0 mi…”10-K · Feb 19, 2026 ↗
Legal and regulatory exposuremixed · 1 filings
“The $34.1 million increase was primarily driven by $20.0 million in litigation and settlement expenses.”10-Q · Aug 6, 2025 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 1.2× · EV/sales 1.4×. Comparisons use only industry-matched filing peers.
Scenario scaffold
Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.
Price action
How the market is pricing the story
17.80-6.9% today
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 11:25 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for TNDM. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for TNDM. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind TNDM
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
BBNXBeta Bionics, Inc.competitorMay 7, 2026 ▾
“We compete in markets worldwide with companies that manufacture insulin delivery devices, primarily Beta Bionics, Insulet, Medtronic, mylife (formerly Ypsomed) and Sequel.”
MDTMedtronic plccompetitorMay 7, 2026 ▾
“We compete in markets worldwide with companies that manufacture insulin delivery devices, primarily Beta Bionics, Insulet, Medtronic, mylife (formerly Ypsomed) and Sequel.”
Depended on by
PODDInsulet CorporationcompetitorFeb 18, 2026 ▾
“We compete with established companies that produce insulin pumps, such as Medtronic Diabetes, a division of Medtronic plc (which division is being spun out into a new, independent publicly traded company), Tandem Diabetes Care Inc., as well as emerging compan…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
TNDM is currently a Follower in the organic co-movement group Media & Financial Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for TNDM; it is not active in the latest market snapshot.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.